Skip to main content
TipRanks
Go Ultimate75% OFF

Syndax Pharmaceuticals (SNDX) Hedge Fund Trading Activity

1,062 Followers
Trend: ▲ Hedge Funds Increased Holdings by 859.2K Shares Last Quarter

Hedge Fund Holdings in SNDX

6.00M$8.509.00M$12.7512.00M$17.0015.00M$21.2518.00M$25.50Jan '25Jul '25Jan '26Jul '26$9.45Stock PriceShares Held by Hedge Funds

Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.

Hedge Fund Confidence Signal

Unlock Hedge Fund Confidence Signal

Hedge Fund Activity​

Activity
Star Ranking
Hedge fund activity
BlackRock, Inc. hedge funds manager,  ,Rank 332BlackRock, Inc. Added2.75%$174,247,048<0.01%
James E. Flynn hedge funds manager, Deerfield Management Company, LP,Rank 31James E. FlynnDeerfield Management Company, LPNot Changed0.00%$71,062,1200.74%
Dennis J Purcell hedge funds manager, Aisling Capital Management LP,Rank 390Dennis J PurcellAisling Capital Management LPNot Changed0.00%$24,755,9535.25%
Michael Rockefeller hedge funds manager, Woodline Partners LP,Rank 458Michael RockefellerWoodline Partners LPNot Changed0.00%$23,514,2880.07%
Kenneth Tropin hedge funds manager, Graham Capital Management, L.P.,Rank 67Kenneth TropinGraham Capital Management, L.P.Not Changed0.00%$368,762<0.01%
John Hussman hedge funds manager, Hussman Strategic Advisors Inc,Rank 374John HussmanHussman Strategic Advisors IncSold Out-100.00%$00.00%

FAQ

Which hedge funds hold Syndax Pharmaceuticals?
The hedge funds that hold the most shares in Syndax Pharmaceuticals are BlackRock, Inc., Michael Rockefeller and Dennis J Purcell.
Are hedge funds buying or selling SNDX?
In the last quarter hedge funds have Increased their holdings in Syndax Pharmaceuticals by 859.2K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Syndax Pharmaceuticals stock?
Warren Buffet currently does not own shares in Syndax Pharmaceuticals.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here